Genetic Data From Over 20,000 U.S. Children Misused for ‘Race Science’
By Mike McIntire,
The New York Times
| 01. 24. 2026
The National Institutes of Health failed to protect brain scans that an international group of fringe researchers used to argue for the intellectual superiority of white people.
Genetic researchers were seeking children for an ambitious, federally funded project to track brain development — a study that they told families could yield invaluable discoveries about DNA’s impact on behavior and disease.
They also promised that the children’s sensitive data would be closely guarded in the decade-long study, which got underway in 2015. Promotional materials included a cartoon of a Black child saying it felt good knowing that “scientists are taking steps to keep my information safe.”
The scientists did not keep it safe.
A group of fringe researchers thwarted safeguards at the National Institutes of Health and gained access to data from thousands of children. The researchers have used it to produce at least 16 papers purporting to find biological evidence for differences in intelligence between races, ranking ethnicities by I.Q. scores and suggesting Black people earn less because they are not very smart.
Mainstream geneticists have rejected their work as biased and unscientific. Yet by relying on genetic and other personal data from the prominent project, known as the Adolescent Brain Cognitive Development Study, the researchers gave...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Nick Paul Taylor, Fierce Biotech | 01.09.2026
Menlo Ventures has made a $16 million bet that the “baby KJ” custom CRISPR therapy success story is repeatable. The funding has enabled CRISPR co-inventor Jennifer Doudna, Ph.D., and baby KJ scientist Fyodor Urnov, Ph.D., to launch Aurora...